Supporting Biotech on their Commercialisation Pathway to Maximise Value from Early Clinical Development to Launch. With Genchrome's team of experienced pharmaceutical experts, we provide commercial & access support to biotech all along the lifecycle from preclinical, phase I,II,II to launch. 🧬 Our Vision - Throughout our experience, we noticed 3 main trends: 1. Nearly half of biotech launches underperformed. 2. Launch Pioneers, despite high level of innovation are overall less successful than established market innovators 3. New biotech launching themselves generally achieve lower sales than in partnership with pharma With our team of international experts with strong pharmaceutical expertise, we want to help you avoid making these mistakes. What We Do: - New Product Launch - Launch Planning - Portfolio Planning - BD and M&A - Payers - Pharma Partnerships Our Fields Of Expertise From Pre-launch To Launch: - Orphan - Neurology - Hemato-Oncology - Oncology - Biosimilars - Hematology - Infectiology - Immunology & Inflammation - Cardiovascular - Nephrology - Ophtalmology For more information, please contact us at: contact@genchrome.com
Looking for a particular Genchrome employee's phone or email?
Genchrome Questions
Caroline Boulliat is the CEO and Founder of Genchrome.
2 people are employed at Genchrome.
Genchrome is based in London, England.
Top Genchrome Employees
Related Companies
